Sang Soo Kang Selected Research

Sang Soo Kang Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 07/2003
11	Seizures (Absence Seizure) 04/2013 - 02/2003
10	Glioma (Gliomas) 12/2023 - 11/2010
8	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2009
7	Hypoxia (Hypoxemia) 01/2022 - 10/2002
7	Ischemia 12/2013 - 09/2002
6	Inflammation (Inflammations) 10/2022 - 06/2012
5	Body Weight (Weight, Body) 11/2022 - 12/2013
5	Ganglion Cysts (Ganglion) 01/2022 - 06/2003
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2021 - 07/2016
5	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2017 - 12/2002
4	Pain (Aches) 10/2019 - 03/2009
4	Glioblastoma (Glioblastoma Multiforme) 05/2018 - 02/2010
3	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2017
3	Diabetes Mellitus 01/2021 - 06/2003
3	Type 2 Diabetes Mellitus (MODY) 08/2020 - 03/2018
3	Carcinogenesis 01/2018 - 02/2014
3	Reperfusion Injury 12/2017 - 10/2003
3	Obesity 09/2015 - 06/2012
3	Stomach Neoplasms (Stomach Cancer) 11/2013 - 04/2009
3	Drug Resistant Epilepsy 12/2006 - 10/2004
2	Cognitive Dysfunction 11/2022 - 04/2016
2	Asthma (Bronchial Asthma) 10/2022 - 07/2017
2	Low Tension Glaucoma 01/2022 - 01/2021
2	Glaucoma 01/2022 - 12/2017
2	Hematoma 04/2021 - 07/2012
2	Brain Neoplasms (Brain Tumor) 05/2018 - 09/2012
2	Macular Degeneration (Age-Related Maculopathy) 12/2017 - 12/2016
2	Neuroinflammatory Diseases 10/2017 - 12/2011
2	Insulin Resistance 01/2016 - 09/2015
2	Memory Disorders (Memory Loss) 01/2016 - 06/2012
2	Acute Kidney Injury (Acute Renal Failure) 12/2013 - 06/2009
2	Neuroblastoma 08/2013 - 09/2006
2	Status Epilepticus (Complex Partial Status Epilepticus) 06/2012 - 11/2010
2	Infarction (Infarctions) 10/2010 - 10/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2006 - 10/2003
2	Brain Injuries (Brain Injury) 10/2005 - 10/2003
1	Hyperplasia 10/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
10	Kainic Acid (Kainate)IBA 04/2013 - 02/2003
8	Retinaldehyde (Retinal)IBA 01/2022 - 03/2003
6	ResveratrolIBA 01/2022 - 12/2011
5	Messenger RNA (mRNA)IBA 01/2019 - 07/2003
4	Antipsychotic Agents (Antipsychotics)IBA 12/2022 - 01/2017
4	CalciumIBA 12/2022 - 10/2008
4	Trifluoperazine (Stelazine)FDA LinkGeneric 12/2022 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 07/2015
4	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 09/2015
4	ClusterinIBA 01/2018 - 06/2003
4	Streptozocin (Streptozotocin)FDA Link 10/2017 - 06/2003
4	Small Interfering RNA (siRNA)IBA 01/2017 - 11/2010
4	TristetraprolinIBA 12/2016 - 01/2015
4	thiamine triphosphorate (TTP)IBA 12/2016 - 01/2015
4	Ethanol (Ethyl Alcohol)IBA 04/2016 - 05/2005
4	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 03/2015 - 04/2009
3	CytokinesIBA 10/2022 - 01/2014
3	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2016
3	Complementary DNA (cDNA)IBA 03/2021 - 12/2002
3	Hypoglycemic Agents (Hypoglycemics)IBA 08/2020 - 01/2014
3	Caspase 3 (Caspase-3)IBA 12/2017 - 11/2010
3	TransferasesIBA 10/2017 - 07/2017
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017 - 10/2008
3	Caffeine (No Doz)FDA LinkGeneric 01/2017 - 02/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 06/2014 - 10/2008
3	Cisplatin (Platino)FDA LinkGeneric 11/2013 - 03/2011
3	Glutamic Acid (Glutamate)FDA Link 04/2013 - 03/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 10/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2006 - 10/2004
3	Betaxolol (Kerlon)FDA LinkGeneric 10/2003 - 09/2002
2	AntioxidantsIBA 10/2022 - 12/2017
2	OvalbuminIBA 10/2022 - 07/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 10/2019 - 03/2009
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 10/2017
2	AcetylglucosamineIBA 01/2019 - 01/2017
2	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 01/2018 - 07/2016
2	NFATC Transcription FactorsIBA 10/2017 - 05/2014
2	Oncogene Proteins (Oncogene Protein)IBA 01/2017 - 07/2016
2	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2017 - 02/2010
2	NF-kappa B (NF-kB)IBA 09/2015 - 12/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2015 - 12/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2015 - 12/2011
2	CalcineurinIBA 06/2014 - 10/2008
2	Carbon Nanotubes (Carbon Nanotube)IBA 10/2013 - 09/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013 - 03/2011
2	deoxyuridine triphosphateIBA 05/2012 - 11/2010
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2012 - 11/2010
2	CaspasesIBA 03/2011 - 06/2009
2	Neuroprotective AgentsIBA 10/2009 - 10/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2006 - 10/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2006 - 10/2002
1	Polycomb Repressive Complex 2IBA 12/2023
1	Estrogens (Estrogen)FDA Link 11/2022
1	IsoflavonesIBA 11/2022

Therapy/Procedure

7	Ketogenic Diet 12/2011 - 02/2003
4	Therapeutics 12/2013 - 10/2004
2	Intraperitoneal Injections 10/2021 - 10/2017
2	Anesthesia 01/2021 - 01/2015
1	Ovariectomy (Oophorectomy) 11/2022